Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1872 1
1887 1
1892 1
1896 1
1916 1
1920 1
1926 1
1928 1
1930 1
1935 5
1937 2
1938 1
1943 1
1945 3
1946 1
1949 7
1950 3
1951 1
1952 3
1953 6
1954 2
1955 2
1956 5
1957 4
1958 6
1959 7
1960 6
1961 4
1962 3
1963 1
1964 7
1965 9
1966 6
1967 5
1968 13
1969 7
1970 7
1971 6
1972 11
1973 12
1974 9
1975 10
1976 23
1977 13
1978 9
1979 11
1980 15
1981 18
1982 18
1983 9
1984 16
1985 19
1986 15
1987 22
1988 25
1989 26
1990 33
1991 38
1992 38
1993 44
1994 37
1995 48
1996 41
1997 40
1998 46
1999 47
2000 59
2001 61
2002 61
2003 62
2004 73
2005 84
2006 71
2007 104
2008 98
2009 111
2010 110
2011 116
2012 136
2013 168
2014 169
2015 167
2016 156
2017 158
2018 173
2019 201
2020 242
2021 253
2022 259
2023 270
2024 133

Text availability

Article attribute

Article type

Publication date

Search Results

3,874 results

Results by year

Filters applied: . Clear all
Page 1
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
Revenko A, Carnevalli LS, Sinclair C, Johnson B, Peter A, Taylor M, Hettrick L, Chapman M, Klein S, Solanki A, Gattis D, Watt A, Hughes AM, Magiera L, Kar G, Ireland L, Mele DA, Sah V, Singh M, Walton J, Mairesse M, King M, Edbrooke M, Lyne P, Barry ST, Fawell S, Goldberg FW, MacLeod AR. Revenko A, et al. Among authors: hughes am. J Immunother Cancer. 2022 Apr;10(4):e003892. doi: 10.1136/jitc-2021-003892. J Immunother Cancer. 2022. PMID: 35387780 Free PMC article. Clinical Trial.
Emergency treatment of anaphylaxis: concise clinical guidance.
Whyte AF, Soar J, Dodd A, Hughes A, Sargant N, Turner PJ. Whyte AF, et al. Among authors: hughes a. Clin Med (Lond). 2022 Jul;22(4):332-339. doi: 10.7861/clinmed.2022-0073. Clin Med (Lond). 2022. PMID: 35882481 Free PMC article.
Debugging and consolidating multiple synthetic chromosomes reveals combinatorial genetic interactions.
Zhao Y, Coelho C, Hughes AL, Lazar-Stefanita L, Yang S, Brooks AN, Walker RSK, Zhang W, Lauer S, Hernandez C, Cai J, Mitchell LA, Agmon N, Shen Y, Sall J, Fanfani V, Jalan A, Rivera J, Liang FX, Bader JS, Stracquadanio G, Steinmetz LM, Cai Y, Boeke JD. Zhao Y, et al. Among authors: hughes al. Cell. 2023 Nov 22;186(24):5220-5236.e16. doi: 10.1016/j.cell.2023.09.025. Epub 2023 Nov 8. Cell. 2023. PMID: 37944511 Free article.
Realizing ecological civilization.
Hughes AC, Wang S. Hughes AC, et al. Ambio. 2023 Dec;52(12):1879-1881. doi: 10.1007/s13280-023-01952-y. Ambio. 2023. PMID: 37934357 No abstract available.
A horizon scan of global biological conservation issues for 2022.
Sutherland WJ, Atkinson PW, Butchart SHM, Capaja M, Dicks LV, Fleishman E, Gaston KJ, Hails RS, Hughes AC, Le Anstey B, Le Roux X, Lickorish FA, Maggs L, Noor N, Oldfield TEE, Palardy JE, Peck LS, Pettorelli N, Pretty J, Spalding MD, Tonneijck FH, Truelove G, Watson JEM, Wentworth J, Wilson JD, Thornton A. Sutherland WJ, et al. Among authors: hughes ac. Trends Ecol Evol. 2022 Jan;37(1):95-104. doi: 10.1016/j.tree.2021.10.014. Epub 2021 Nov 19. Trends Ecol Evol. 2022. PMID: 34809998 Review.
Conventional heart failure therapy in cardiac ATTR amyloidosis.
Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU, Jiang A, Cabras G, Filisetti S, Bolhuis RE, Bandera F, Venneri L, Martinez-Naharro A, Law S, Kotecha T, Virsinskaite R, Knight DS, Emdin M, Petrie A, Lachmann H, Wechelakar A, Petrie M, Hughes A, Freemantle N, Hawkins PN, Whelan C, McMurray JJV, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: hughes a. Eur Heart J. 2023 Aug 14;44(31):2893-2907. doi: 10.1093/eurheartj/ehad347. Eur Heart J. 2023. PMID: 37216684 Free PMC article.
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
ACTIV-3/TICO Study Group; Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, Rapti V, Lye DC, Hui DS, Leither L, Knowlton KU, Jain MK, Marines-Price R, Osuji A, Overcash JS, Kalomenidis I, Barmparessou Z, Waters M, Zepeda K, Chen P, Torbati S, Kiweewa F, Sebudde N, Almasri E, Hughes A, Bhagani SR, Rodger A, Sandkovsky U, Gottlieb RL, Nnakelu E, Trautner B, Menon V, Lutaakome J, Matthay M, Robinson P, Protopapas K, Koulouris N, Kimuli I, Baduashvili A, Braun DL, Günthard HF, Ramachandruni S, Kidega R, Kim K, Hatlen TJ, Phillips AN, Murray DD, Jensen TO, Padilla ML, Accardi EX, Shaw-Saliba K, Dewar RL, Teitelbaum M, Natarajan V, Laverdure S, Highbarger HC, Rehman MT, Vogel S, Vallée D, Crew P, Atri N, Schechner AJ, Pett S, Hudson F, Badrock J, Touloumi G, Brown SM, Self WH, North CM, Ginde AA, Chang CC, Kelleher A, Nagy-Agren S, Vasudeva S, Looney D, Nguyen HH, Sánchez A, Weintrob AC, Grund B, Sharma S, Reilly CS, Paredes R, Bednarska A, Gerry NP, Babiker AG, Davey VJ, Gelijns AC, Higgs ES, Kan V, Matthews G, Thompson BT, Legenne P, Chandra R, Lane HC, Neato… See abstract for full author list ➔ ACTIV-3/TICO Study Group, et al. Among authors: hughes a. Ann Intern Med. 2022 Sep;175(9):1266-1274. doi: 10.7326/M22-1503. Epub 2022 Aug 9. Ann Intern Med. 2022. PMID: 35939810 Free PMC article. Clinical Trial.
Immune-mediated colitis associated with ocrelizumab: A new safety risk.
Kim T, Brinker A, Croteau D, Lee PR, Baldassari LE, Stevens J, Hughes A, Tomaino J, deFonseka A, Altepeter T, Kortepeter CM. Kim T, et al. Among authors: hughes a. Mult Scler. 2023 Sep;29(10):1275-1281. doi: 10.1177/13524585231195854. Mult Scler. 2023. PMID: 37706451 Review.
3,874 results